This article provided by ONU HealthWise Pharmacy.
The US Food and Drug Administration (FDA) has approved the first injectable medication for cellulite.
This medication is called Qwo (collagenase clostridium histolyticum-aaes). The FDA approved it to treat adult women with moderate to severe cellulite in the buttocks.
Qwo comes in the form of an injection and is given under the skin (subcutaneously) of each buttock by your health care provider.
This column is provided by the ONU HealthWise Pharmacy.
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a saliva test for SARS-CoV-2, the virus that causes COVID-19 infection.
This approval was granted to the Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test.
This column is provided by ONU HealthWise Pharmacy.
Kidney stones may be small, but they can pack a lot of pain. Read on to find out how you can reduce your chance of developing kidney stones.
Kidney stones form in the kidneys and can cause discomfort and pain. They can be small, but large ones can become stuck in the urinary tract, blocking the flow of urine and causing intense pain.
This column is provided by Ohio Northern University HealthWise Pharmacy.
All lots of Ferring Pharmaceuticals' multi-condition nasal spray are being recalled.
The problem? These lots have higher-than-specified amounts of desmopressin.
Higher amounts of desmopressin can lead to abnormally low levels of sodium in the blood. And very low levels of sodium in the blood can lead to dangerous health events, such as seizures, coma and even death.
This column provided by ONU HealthWise Pharmacy.
Spravato (esketamine) is considered the first big advancement in depression treatment since the approval of Prozac — and it just got approved for a new use.
Approved for treatment-resistant depression (TRD) in March of 2019, esketamine is now approved to treat depressive symptoms in adults with major depressive disorder (MDD) and acute suicidal ideation or behavior.
This column is provided by the ONU HealthWise Pharmacy.
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a new COVID-19 diagnostic test that can test people who are not showing symptoms.
This test is found under the name LabCorp COVID-19 RT-PCR.
This test was originally given an EUA in early March. It was to test those whose health care providers suspected that they might have COVID-19, and it only tested individual specimens (no sample pooling). But that changed with this new EUA from the FDA.
